Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 A case of relapsing and refractory catastrophic anti-phospholipid syndrome successfully managed with eculizumab, a complement 5 inhibitor.

× No keyword cloud information.

19 in total

Review 1. The rheumatology/hematology interface: CAPS and MAS diagnosis and management.

Authors: John M Gansner; Nancy Berliner
Journal: Hematology Am Soc Hematol Educ Program Date: 2018-11-30

Review 2. Clinical Risk Assessment in the Antiphospholipid Syndrome: Current Landscape and Emerging Biomarkers.

Authors: Shruti Chaturvedi; Keith R McCrae
Journal: Curr Rheumatol Rep Date: 2017-07 Impact factor: 4.592

Review 3. Antibodies Against Complement Components: Relevance for the Antiphospholipid Syndrome-Biomarkers of the Disease and Biopharmaceuticals.

Authors: Mirjana Bećarević
Journal: Curr Rheumatol Rep Date: 2017-07 Impact factor: 4.592

Review 4. Antiphospholipid syndrome: Complement activation, complement gene mutations, and therapeutic implications.

Authors: Shruti Chaturvedi; Evan M Braunstein; Robert A Brodsky
Journal: J Thromb Haemost Date: 2021-02-10 Impact factor: 5.824

Review 5. Diagnosis and management of the antiphospholipid syndrome.

Authors: Shruti Chaturvedi; Keith R McCrae
Journal: Blood Rev Date: 2017-07-30 Impact factor: 8.250

Review 6. Complementopathies and precision medicine.

Authors: Eleni Gavriilaki; Robert A Brodsky
Journal: J Clin Invest Date: 2020-05-01 Impact factor: 14.808

Review 7. Pediatric antiphospholipid syndrome.

Authors: Jacqueline A Madison; Yu Zuo; Jason S Knight
Journal: Eur J Rheumatol Date: 2019-12-03

Review 8. Use of eculizumab in a systemic lupus erythemathosus patient presenting thrombotic microangiopathy and heterozygous deletion in CFHR1-CFHR3. A case report and systematic review.

Authors: Maria Izabel de Holanda; Luis Cristóvão Pôrto; Teresa Wagner; Luis Fernando Christiani; Lilian M P Palma
Journal: Clin Rheumatol Date: 2017-09-13 Impact factor: 2.980

Review 9. Diagnosing antiphospholipid syndrome: 'extra-criteria' manifestations and technical advances.

Authors: Savino Sciascia; Mary-Carmen Amigo; Dario Roccatello; Munther Khamashta
Journal: Nat Rev Rheumatol Date: 2017-08-03 Impact factor: 20.543

Review 10. HUS and atypical HUS.

Authors: T Sakari Jokiranta
Journal: Blood Date: 2017-04-17 Impact factor: 25.476